— Know what they know.
Not Investment Advice

NBIO OTC

Nascent Biotech, Inc.
1W: +0.0% 1M: -33.3% 3M: -60.0% YTD: -66.7% 1Y: -97.1% 3Y: -99.7% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 45 · $34443 mcap · 99M float · 0.027% daily turnover · Short 80% of daily vol

Balance Sheet Trends

Total Assets
$552K +116.5% ▲
5Y CAGR: +33.2%
Total Liabilities
$809K -47.9% ▼
5Y CAGR: +5.7%
Shareholders Equity
-$257K +80.2% ▲
Cash & Investments
$372K +116.1% ▲
5Y CAGR: +23.1%
Total Debt
$122K -68.6% ▼
Net Debt
-$250K -214.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$3K$1K$94K$172K$372K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3K$1K$94K$172K$372K
Net Receivables$0$750K$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$3K$751K$105K$255K$552K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$0
Total Assets$3K$751K$105K$255K$552K
— Liabilities —
Accounts Payable$739K$538K$777K$498K$686K
Short-Term Debt$139K$162K$0$390K$122K
Deferred Revenue$1M$123K$0$0$0
Other Current Liabilities$718K$401K$0$663K$0
Total Current Liabilities$3M$1M$777K$2M$809K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$991K$799K$777K$0$0
Total Liabilities$3M$1M$777K$2M$809K
— Equity —
Common Stock$45K$105K$111K$132K$171K
Retained Earnings-$17M-$18M-$19M-$22M-$24M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$3M-$473K-$671K-$1M-$257K
Total Liabilities & Equity$3K$751K$105K$255K$552K
— Key Metrics —
Total Debt$139K$162K$0$390K$122K
Net Debt$136K$160K-$94K$217K-$250K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms